MedTrace Logo

Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia

NCT05430893 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-09-15

No results posted yet for this study

Summary

Chronic athletic pubalgia is a frequent sport condition in which the effectiveness of medical treatment has not been proven. Intra-muscular injection of botulinum toxin A may have positive effects on pain in some chronic tendinitis.

The investigators hypothesized that similar analgesic effect of intra-muscular botulinum toxin A may be observed in individuals with chronic AP. In the present study, the investigators aimed to describe the short-term evolution of pain and of activity limitations and quality of life, after an injection of the adductor longus with botulinum toxin A, in individuals with chronic AP, for whom medical and/or surgical treatments have failed.

Conditions

  • Athletic Pubalgia

Interventions

OTHER

Botulinum Toxin A

100 UI IM in the adductor longus

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Romain GAROFOLI · Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)

  • Marie-Martine Lefevre-Colau, MD, PhD · Cochin Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2021-03-31
Completion
2021-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05430893 on ClinicalTrials.gov